Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.
published in in April 2013. the authors say that "The PacBio RS instrument was selected as the NGS platform
for this study based on its rapidity of analysis and following
validation using a set of 30 blood and FFPE samples (27 with
known cancer mutations)." can't imaging using illumina machine for this kind of work and only can get results several days well after collecting sample.